Clinical trial
Prospective Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma
NCT04129281 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma
- Lead sponsor
- National Cancer Institute, Naples
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 23, 2019
- Completion date
- February 23, 2024
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
papillary microcarcinoma of the thyroid